跳至主要内容
临床试验/IRCT201202229014N2
IRCT201202229014N2Other3 期

Effect of helicobacter pylori eradication regimen versus standard treatment on gastro-esophageal reflux symptoms in patients with antral gastritis: a triple blinded randomized controlled trial

Vic-chancellor of Research and Technology, Hamadan University of Medical Sciences0 个研究点目标入组 162 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
Other
发起方
入组人数
162

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • The patient's with one of the following symptoms: gastro-esophageal reflux, dysphagia; heartburn; nausea; chest pain; and nuisance conditions that lead to awakening the patient will be included if they have endoscopic detection of gastritis and H. pylori infection in biopsy of gastric mucosa.
  • The patents with following characteristics will be excluded from the study: simultaneous gastritis of fundus and antrum (pangastritis); gastric ulcer; duodenal ulcer; surgical history of esophagus, stomach, or duodenum; and history of using NSAIDs.

排除标准

  • 未提供

研究者

发起方
Vic-chancellor of Research and Technology, Hamadan University of Medical Sciences

相似试验